Cargando…

Antibody levels following booster SARS-CoV-2 vaccination among dialysis patients initially vaccinated with adenovirus vector-based vaccine

Detalles Bibliográficos
Autores principales:	Willetts, Joanna, Ficociello, Linda H., Johnson, Curtis D., Alexander, Sandra E., Mullon, Claudy, Hymes, Jeffrey L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869304/ https://www.ncbi.nlm.nih.gov/pubmed/36689169 http://dx.doi.org/10.1007/s40620-022-01559-8

Ejemplares similares

Full and Booster Doses of SARS-CoV-2 mRNA-1273 Vaccine Increase Waning Antibody Levels After Completed Vaccination Among Dialysis Patients at a Large Dialysis Organization
por: Ficociello, Linda H, et al.
Publicado: (2022)

Antibody Response to the Coronavirus Disease 2019 Ad26.COV2.S Vaccine Among Maintenance Dialysis Patients
por: Ficociello, Linda H., et al.
Publicado: (2022)

Impact of various vaccine boosters on neutralization against omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine
por: Huang, Qingrui, et al.
Publicado: (2022)

Adenoviruses as vaccine vectors
por: Tatsis, Nia, et al.
Publicado: (2004)

Simian adenoviruses as vaccine vectors
por: Morris, Susan J, et al.
Publicado: (2016)

Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2021)

Effect of Citrate-Acidified Dialysate on Intact Parathyroid Hormone in Prevalent Hemodialysis Patients: A Matched Retrospective Cohort Study
por: Ficociello, Linda H, et al.
Publicado: (2021)

Development of nonhuman adenoviruses as vaccine vectors
por: Bangari, Dinesh S., et al.
Publicado: (2006)

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method
por: Roy, Chad J, et al.
Publicado: (2011)

Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide
por: Gray, Kathryn, et al.
Publicado: (2019)

Real-World Performance of High-Flux Dialyzers in Patients With Hypoalbuminemia
por: Zhou, Meijiao, et al.
Publicado: (2021)

A real-world analysis of the influence of age on maintenance hemodialysis patients: managing serum phosphorus with sucroferric oxyhydroxide as part of routine clinical care
por: Rhee, Connie M., et al.
Publicado: (2022)

Adenoviruses as vectors for delivering vaccines to mucosal surfaces
por: Babiuk, L.A, et al.
Publicado: (2000)

Adenovirus Vectors: Excellent Tools for Vaccine Development
por: Chang, Jun
Publicado: (2021)

COVID-19 Vaccines Based on Adenovirus Vectors
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2021)

Adenovirus vector-based vaccine for infectious diseases
por: Sakurai, Fuminori, et al.
Publicado: (2022)

Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants
por: Zhong, Jiaying, et al.
Publicado: (2022)

Development of an adenovirus vector vaccine platform for targeting dendritic cells
por: Sharma, Piyush K, et al.
Publicado: (2017)

Development of replication-competent adenovirus based vaccine vectors
por: Abbink, P, et al.
Publicado: (2012)

Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines
por: Borovjagin, Anton V., et al.
Publicado: (2014)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Ulaszewska, Marta, et al.
Publicado: (2023)

Adeno-Associated Virus as an Effective Malaria Booster Vaccine Following Adenovirus Priming
por: Yusuf, Yenni, et al.
Publicado: (2019)

Adenovirus Vaccines
por: Gray, Gregory C., et al.
Publicado: (2018)

Serum Phosphorus and Pill Burden Among Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide: One-Year Follow-Up on a Contemporary Cohort
por: Kendrick, Jessica B, et al.
Publicado: (2022)

Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: “Adenovirus Vaccine Within an Adenovirus Vector”
por: Yan, Yuqian, et al.
Publicado: (2020)

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
por: Maxfield, Lori F., et al.
Publicado: (2015)

Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines
por: Weaver, Eric A., et al.
Publicado: (2013)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
por: Koger-Pease, Cal, et al.
Publicado: (2023)

Opinion Polls and Antibody Response Dynamics of Vaccination with COVID-19 Booster Vaccines
por: Wu, Yufei, et al.
Publicado: (2022)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
por: Collignon, Catherine, et al.
Publicado: (2020)

An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice
por: Kim, Eun Hye, et al.
Publicado: (2017)

Sucroferric Oxyhydroxide in Maintenance Hemodialysis: A Retrospective, Comparative Cohort Study
por: Coyne, Daniel W., et al.
Publicado: (2020)

Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2019)

Myocarditis following AstraZeneca (an adenovirus vector vaccine) COVID‐19 vaccination: A case report
por: Hassanzadeh, Shakiba, et al.
Publicado: (2022)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
por: Lewis, Nathaniel M, et al.
Publicado: (2022)

Development of a novel simian adenovirus 24 based vaccine vector
por: Abbink, P, et al.
Publicado: (2012)

Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
por: Afkhami, Sam, et al.
Publicado: (2016)

Use of adenovirus type-5 vectored vaccines: a cautionary tale
por: Buchbinder, Susan P, et al.
Publicado: (2020)

Booster Vaccination: The Role of Reduced Antigen Content Vaccines as a Preschool Booster
por: Gabutti, Giovanni, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_is7hufqprbd0m9vnne81jav3sd